Tag: Nate Giesselman
Skadden, Latham & Watkins steer USD1.12bn biotech sale
Skadden and Latham & Watkins are advising Otsuka Pharmaceutical on its USD1.12 billion acquisition of Jnana Therapeutics
Skadden and Latham & Watkins are advising Otsuka Pharmaceutical on its USD1.12 billion acquisition of Jnana Therapeutics
IHCF vice president SongYi Son discusses the merits and possible obstacles for doing business in South Korea
Follow us on LinkedIn